Introduction: Changes in lifestyle are responsible for an important part of the type 2 diabetes epidemic of the last decennia. Current guidelines for physical activity focus mainly on high energy expenditure advising 30 minutes per day moderate to vigorous physical activity (most often physical exercise). Recent studies suggest that sitting has negative metabolic effects independent of the time spent exercising (Duvivier et al. PLOS ONE 2013). Low intensity physical activity (LIPA) -such as walking and standing- has been suggested to be an alternative to decrease the hyperglycaemic effect of sitting. Compared to exercise, LIPA might be a more feasible strategy. But, it remains to be determined whether reducing sitting time by replacing it by LIPA, results in lower 24 hour blood glucose levels and less blood glucose fluctuations (glycaemic variability) in type 2 diabetes patients and whether these effects are independent of the increase in energy expenditure Methods: The study population will involve 19 people with type 2 diabetes (BMI: 25-35 kg/m2) who perform no, or only little, exercise and who are treated with diet only or with oral blood glucose lowering medication. They will perform three regimes of each four days: 1) a sitting regime, 2) an exercise regime and a 3) sit less regime. Daily energy expenditure of the exercise regime will be identical to that of the sit less regime. Sitting, walking and standing will be objectively measured by a 24 hour physical activity monitor. The energy spent during exercise will be standardised and quantified by using a bicycle ergometer; energy intake will be standardised as well. During each regime blood glucose will be measured with a 24 hour continuous glucose sensor.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
19
Human Movement Science, Maastricht University
Maastricht, Limburg, Netherlands
Mean 24 hour glucose concentration
Time frame: during the last 24 hours of an activity regime
Total duration (minutes) of hyperglycaemia (glucose > 10 mmol/L)
Time frame: during the last 24 hours of an activity regime
Mean 24 hour glucose concentration
Time frame: during a whole activity regime
Total duration of hyperglycaemia (glucose > 10 mmol/L)
Time frame: during a whole activity regime
Area under the curve of hyperglycaemia (glucose > 10 mmol/L)
Time frame: during the last 24 hours of an activity regime
Glucose variability measured as SD divided by mean
Time frame: the last 24 hours of each regime
Total duration of hypoglycaemia (glucose ≤ 3.9 mmol/L)
Time frame: during a whole activity regime
Fasting total cholesterol
Time frame: one day after each activity regime
Non-HDL cholesterol
Time frame: one day after each activity regime
HDL cholesterol
Time frame: one day after each activity regime
LDL cholesterol
Time frame: one day after each activity regime
Triglycerides
Time frame: one day after each activity regime
Apolipoprotein B
Time frame: one day after each activity regime
Apolipoprotein A
Time frame: one day after each activity regime
Free fatty acids
Time frame: one day after each activity regime
Fasting glucose
Time frame: one day after each activity regime
Fasting insulin
Time frame: one day after each activity regime
Fasting C-peptide
Time frame: one day after each activity regime
Fasting CRP
Time frame: one day after each activity regime
Fasting IL-6
Time frame: one day after each activity regime
Fasting IL-1
Time frame: one day after each activity regime
Homeostatic model assessment 2 (HOMA2)
to assess insulin sensitivity
Time frame: one day after each activity regime
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.